Publications

Authors: Michael Vallis, Hana Ryan, Lori Berard, Emmanuel Cosson, Finn Boerlum Kristensen, Fleur Levrat-Guillen, Nicolas Naiditch, Remi Rabasa-Lhoret, William Polonsky Abstract Objectives: Motivation to adhere to clinical recommendations requires engagement, and the urgency to act is one of many factors that contribute to achieving glycemic benefits in people with type 2 diabetes (PwT2D). Continuous glucose monitoring (CGM) devices are associated

Authors: William H Polonsky, Addie L Fortmann, Emily C Soriano, Susan J Guzman, Martha M Funnell Abstract Background: The majority of individuals referred to diabetes self-management education and support (DSMES) programs do not access this resource. Of those who do, attrition is high, with anecdotal reports pointing to the didactic and impersonal nature of these programs contributing to low utilization

Authors: William H Polonsky, Korey K Hood, Carol J Levy, Sarah A MacLeish, Irl B Hirsch, Sue A Brown, Bruce W Bode, Anders L Carlson, Viral N Shah, Ruth S Weinstock, Anuj Bhargava, Thomas C Jones, Grazia Aleppo, Sanjeev N Mehta, Lori M Laffel, Gregory P Forlenza, Jennifer L Sherr, Lauren M Huyett, Todd E Vienneau, Trang T Ly, Omnipod

Authors: L Fisher, W H Polonsky, M Perez-Nieves, U Desai, L Strycker, D Hessler Abstract Aims: To establish cut-points and thresholds for elevated diabetes distress; document change over time; and define minimal clinically important differences (MCID) using the new Type 2 Diabetes Distress Assessment System (T2-DDAS). Methods: A national sample of adults with type 2 diabetes completed the T2-DDAS CORE

Authors: Emily C Soriano, William H Polonsky Abstract Background: To examine the impact of real-time continuous glucose monitoring (rtCGM) on psychosocial outcomes in adults with insulin-using type 2 diabetes (T2D). Methods: A total of 174 insulin-using adults with T2D completed questionnaires assessing diabetes distress, hypoglycemic confidence, hypoglycemic fear, device-related emotional burden, and device-related trust before and after a six-month trial

Authors: William H Polonsky, Emily C Soriano, Addie L Fortmann Abstract Background: To explore whether regularly reviewing one’s own retrospective continuous glucose monitoring (CGM) data might be linked with perceived quality of life (QoL) and glycemic benefits. Methods: Adults with type 1 diabetes (N = 300) or insulin-using type 2 diabetes (N = 198) using the Dexcom G5 Mobile or

Authors: David C Klonoff, Jing Wang, David Rodbard, Michael A Kohn, Chengdong Li, Dorian Liepmann, David Kerr, David Ahn, Anne L Peters, Guillermo E Umpierrez, Jane Jeffrie Seley, Nicole Y Xu, Kevin T Nguyen, Gregg Simonson, Michael S D Agus, Mohammed E Al-Sofiani, Gustavo Armaiz-Pena, Timothy S Bailey, Ananda Basu, Tadej Battelino, Sewagegn Yeshiwas Bekele, Pierre-Yves Benhamou, B Wayne Bequette,

Authors: Aaisha Farooqi, Clare Gillies, Harini Sathanapally, Sophia Abner, Sam Seidu, Melanie J Davies, William H Polonsky, Kamlesh Khunti Abstract Aims: Diabetes can significantly impact quality of life and mental health. However, inconsistencies have been reported in the prevalence of depression in those with Type 1 and Type 2 diabetes, and those without. Systematic reviews also included studies without adequate

Authors: Marc Evans, Susanne Engberg, Mads Faurby, João Diogo Da Rocha Fernandes, Pollyanna Hudson, William Polonsky Abstract We designed a systematic literature review to identify available evidence on adherence to and persistence with antidiabetic medication in people with type 2 diabetes (T2D). Electronic screening and congress searches identified real-world noninterventional studies (published between 2010 and October 2020) reporting estimates of

Authors: Stephanie Edwards, Xuanyao He, Wenjie Wang, Jiat-Ling Poon, Eric Meadows, David Price, Jennal Johnson, Howard Wolpert, William Polonsky Abstract Objective: This study used connected pen to determine missed bolus dose (MBD) frequency during masked and unmasked continuous glucose monitoring (CGM) periods and examined its link with time-in-range (TIR), time-above-range (TAR), time-below-range (TBR), and key participant characteristics in people with